All In Biotech

Drug Trial Radar · NCT07141004

A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

A Phase-IV, Multicenter, Non-Comparative, Open-Label Study Evaluating the Safety and Efficacy of Guselkumab Administered Subcutaneously in the Treatment of Indian Patients With Psoriatic Arthritis

Last checked: Nov 20, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Aug 12, 2025

Primary completion

Jun 5, 2027

Study completion Sep 11, 2027

Sponsor

Lead sponsor
Johnson & Johnson Private LimitedJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Aug 26, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and how well guselkumab treatment works (efficacy) in participants with psoriatic arthritis (PsA; a chronic, autoimmune form of arthritis that causes joint inflammation) who had inadequate response to standard therapies.

Conditions

  • Arthritis, Psoriatic

Interventions

  • GuselkumabDrug

    Guselkumab will be administered as subcutaneous injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Adverse Events (AEs)Time frame: Up to 32 weeks
  2. Number of Participants With Serious Adverse Events (SAEs)Time frame: Up to 32 weeks

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Cims Hospital

    Ahmedabad, India · Recruiting

  • Post Graduate Institute of Medical Education And Research PGIMER

    Chandigarh, India · Recruiting

  • Chennai Meenakshi Multispeciality Hospital

    Chennai, India · Recruiting

  • All India Institute of Medical Sciences 1

    Gorakhpur, India · Recruiting

  • ESIC Medical College and Hospital

    Hyderabad, India · Recruiting

  • Nizams Institute of Medical Sciences

    Hyderabad, India · Recruiting

  • P. D. Hinduja National Hospital and Research Center

    Mumbai, India · Recruiting

  • All India Institute of Medical Sciences

    New Delhi, India · Recruiting

  • Sir Ganga Ram Hospital

    New Delhi, India · Recruiting

  • All India Institute of Medical Sciences

    Patna, India · Recruiting

  • Jehangir Clinical Development Centre

    Pune, India · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.